Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Review the sources used below for this article: This article references information from the study in American Chemistry Association: Fat-trapping microbeads provide drug-free weight loss in rats, study finds This article references information from content from the Mayo Clinic: Orlistat This article references information from content from Cleveland Clinic: GLP-1 Agonists
Despite recent progress in antifungal therapy and the advancement of several novel agents into clinical trials, the rapid emergence of antifungal resistance has emerged as a critical barrier to effective treatment and is now recognized by the World Health Organization as one of the top ten global public health threats (Ferdinand et al., 2023
doi: 10.1158/1538-7445.AM2011-1248 27 Menendez-MontesISolmonsonAMAcedo-PereiraAHCardosoACNakadaYThetSet al
Del Prato S, Kahn SE, Pavo I et al (2021) Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Lendvai B, Vizi ES (2008) Nonsynaptic chemical transmission through nicotinic acetylcholine receptors
US$ 27.19
US$ 27.32
US$ 24.06
US$ 23.00
US$ 20.97
